FDA Requests Public Comments on the Use of Antimicrobials in Companion Animals Today, the U.S. Food and Drug Administration released a request for public comments about antimicrobial use (AMU) in companion animals (e.g., cats, dogs, horses) and the potential impact of this use on antimicrobial resistance in both animals and people. The FDA's Center for Veterinary Medicine (CVM) intends to use the information collected to help develop strategies to further promote antimicrobial stewardship in companion animals. Although most of the FDA's animal antimicrobial stewardship efforts to-date have been related to food-producing animals, the FDA recognizes that there is also a need to better understand how the use of antimicrobial drugs to treat companion animals (e.g., dogs, cats, and horses) might contribute to the development of antimicrobial resistance in both animals and people. This is in alignment with the One Health philosophy, which recognizes the interconnectedness of the health of people, animals, and the environment. You are subscribed to updates from FDA's Center for Veterinary Medicine. |
No comments:
Post a Comment